# Nonspecific peripheral T cell lymphoma combined with pure red cell aplasia: a case report and literature review

**Authors:** 学亚 张, 瑜瑜 郑, 大铬 范, 金发 钟, 诗馨 吴

PMC · DOI: 10.3760/cma.j.cn121090-20240809-00297 · Chinese Journal of Hematology · 2025-04-01

## TL;DR

This paper reports a rare case of peripheral T cell lymphoma combined with pure red cell aplasia and describes the patient's response to treatment.

## Contribution

The novelty lies in the detailed clinical and pathological analysis of a rare co-occurrence of PTCL-NOS and PRCA.

## Key findings

- The patient showed significant improvement after ECHOP chemotherapy and maintenance treatment with lenalidomide.
- Bone marrow recovery and normalization of red blood cell production were observed.
- CD3+CD8+ T lymphocytes were no longer detectable post-treatment.

## Abstract

外周T细胞淋巴瘤非特指型（PTCL-NOS）合并纯红细胞再生障碍（PRCA）国内报道较少。本文报道1例PTCL-NOS患者，以重度贫血为首发表现，伴有多部位淋巴结肿大。实验室检查证实红细胞减少、网织红细胞比例降低、骨髓红细胞增生明显减低，骨髓CD3+CD8+ T淋巴细胞比例显著增高，淋巴结病理及免疫组化符合PTCL-NOS，TCRβ基因重排阳性，一线ECHOP方案化疗4个疗程后，患者肿大淋巴结显著缩小，全身CT评估部分缓解，血红蛋白升至正常，骨髓造血红系增生恢复正常，CD3+CD8+ T淋巴细胞未检出，目前口服来那度胺维持治疗，预后尚好。

## Linked entities

- **Chemicals:** lenalidomide (PubChem CID 216326)
- **Diseases:** peripheral T cell lymphoma (MONDO:0000430), pure red cell aplasia (MONDO:0001705)

## Full-text entities

- **Genes:** TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** lymphadenopathy (MESH:D008206), PRCA (MESH:D012010), Nonspecific peripheral T-cell lymphoma (MESH:D016411), anemia (MESH:D000740)
- **Chemicals:** ECHOP (-), lenalidomide (MESH:D000077269)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12158807/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12158807/full.md

---
Source: https://tomesphere.com/paper/PMC12158807